12.97
price down icon1.22%   -0.16
after-market After Hours: 12.96 -0.010 -0.08%
loading

Bicara Therapeutics Inc Stock (BCAX) Forecast

The Bicara Therapeutics Inc (BCAX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $12.97. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCAX Price Target
Average 0.00 (-100.00% Downside)
loading

Is Bicara Therapeutics Inc (BCAX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 48.43 Neutral
STOCH(9,6) 28.11 Neutral
STOCHRSI(14) 26.20 Neutral
MACD(12,26) 0.1521 Sell
ADX(14) 15.57 Neutral
William %R -70.19 Neutral
CCI(14) -35.36 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
13.79
Sell
13.37
Sell
MA20
13.38
Sell
13.30
Sell
MA50
13.11
Sell
13.30
Sell
MA100
13.65
Sell
14.88
Sell
MA200
13.83
Sell
0.00
Buy
Buy: 1 Sell: 9 Neutral: 0
Summary: Sell
According to our latest analysis, BCAX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on BCAX, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 48.43 indicates that BCAX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 28.11 indicates that BCAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 26.2 indicates that BCAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 15.57 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -35.36 indicates that BCAX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Bicara Therapeutics Inc Stock (BCAX) Year by Year Forecast

$65.08
price down icon 0.84%
$19.36
price down icon 0.31%
$33.15
price up icon 0.15%
$23.96
price down icon 2.80%
$92.77
price down icon 2.12%
biotechnology ONC
$231.99
price down icon 1.67%
Cap:     |  Volume (24h):